ALKEMPharmaceuticals
Alkem Laboratories Ltd — Profit & Loss Statement
₹5299.00
-1.40%
Alkem Laboratories Ltd Profit & Loss Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Diluted EPS | 181.11 | 150.19 | 82.31 | 137.63 | — |
| Tax Effect Of Unusual Items | 5.38 Cr | -11.50 Cr | -19.76 Cr | -0.24 Cr | — |
| Tax Rate For Calcs | 0.12 | 0.10 | 0.23 | 0.09 | — |
| Normalized EBITDA | 2.93K Cr | 2.53K Cr | 1.80K Cr | 2.19K Cr | — |
| Total Unusual Items | 43.76 Cr | -109.50 Cr | -86.65 Cr | -2.66 Cr | — |
| Total Unusual Items Excluding Goodwill | 43.76 Cr | -109.50 Cr | -86.65 Cr | -2.66 Cr | — |
| Net Income From Continuing Operation Net Minority Interest | 2.17K Cr | 1.80K Cr | 984.17 Cr | 1.65K Cr | — |
| Reconciled Depreciation | 357.16 Cr | 299.30 Cr | 310.42 Cr | 303.96 Cr | — |
| Reconciled Cost Of Revenue | 4.86K Cr | 5.03K Cr | 4.98K Cr | 4.28K Cr | — |
| EBITDA | 2.97K Cr | 2.42K Cr | 1.71K Cr | 2.19K Cr | — |
| EBIT | 2.61K Cr | 2.12K Cr | 1.40K Cr | 1.89K Cr | — |
| Net Interest Income | 237.08 Cr | 163.36 Cr | 63.78 Cr | 70.31 Cr | — |
| Interest Expense | 87.24 Cr | 95.71 Cr | 93.75 Cr | 40.84 Cr | — |
| Interest Income | 358.78 Cr | 275.77 Cr | 171.14 Cr | 122.68 Cr | — |
| Normalized Income | 2.13K Cr | 1.89K Cr | 1.05K Cr | 1.65K Cr | — |
| Net Income From Continuing And Discontinued Operation | 2.17K Cr | 1.80K Cr | 984.17 Cr | 1.65K Cr | — |
| Total Expenses | 10.62K Cr | 10.45K Cr | 10.11K Cr | 8.74K Cr | — |
| Rent Expense Supplemental | 10.08 Cr | 9.60 Cr | 9.78 Cr | 6.43 Cr | — |
| Diluted Average Shares | 11.96 Cr | 11.96 Cr | 11.96 Cr | 11.96 Cr | — |
| Basic Average Shares | 11.96 Cr | 11.96 Cr | 11.96 Cr | 11.96 Cr | — |
| Basic EPS | 181.11 | 150.19 | 82.31 | 137.63 | — |
| Diluted NI Availto Com Stockholders | 2.17K Cr | 1.80K Cr | 984.17 Cr | 1.65K Cr | — |
| Net Income Common Stockholders | 2.17K Cr | 1.80K Cr | 984.17 Cr | 1.65K Cr | — |
| Otherunder Preferred Stock Dividend | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Income | 2.17K Cr | 1.80K Cr | 984.17 Cr | 1.65K Cr | — |
| Minority Interests | -49.90 Cr | -15.69 Cr | -22.64 Cr | -34.70 Cr | — |
| Net Income Including Noncontrolling Interests | 2.22K Cr | 1.81K Cr | 1.01K Cr | 1.68K Cr | — |
| Net Income Continuous Operations | 2.22K Cr | 1.81K Cr | 1.01K Cr | 1.68K Cr | — |
| Tax Provision | 311.03 Cr | 211.67 Cr | 297.96 Cr | 163.96 Cr | — |
| Pretax Income | 2.53K Cr | 2.02K Cr | 1.30K Cr | 1.84K Cr | — |
| Other Non Operating Income Expenses | 23.96 Cr | 17.92 Cr | 12.33 Cr | 9.11 Cr | — |
| Special Income Charges | -9.13 Cr | -124.67 Cr | -117.51 Cr | -14.11 Cr | — |
| Other Special Charges | -4.60 Cr | 124.67 Cr | 115.34 Cr | -1.97 Cr | — |
| Impairment Of Capital Assets | 13.73 Cr | 0.00 | 2.17 Cr | 1.12 Cr | — |
| Net Non Operating Interest Income Expense | 237.08 Cr | 163.36 Cr | 63.78 Cr | 70.31 Cr | — |
| Total Other Finance Cost | 34.46 Cr | 16.70 Cr | 13.61 Cr | 11.53 Cr | — |
| Interest Expense Non Operating | 87.24 Cr | 95.71 Cr | 93.75 Cr | 40.84 Cr | — |
| Interest Income Non Operating | 358.78 Cr | 275.77 Cr | 171.14 Cr | 122.68 Cr | — |
| Operating Income | 2.18K Cr | 1.98K Cr | 1.33K Cr | 1.77K Cr | — |
| Operating Expense | 5.76K Cr | 5.42K Cr | 5.12K Cr | 4.46K Cr | — |
| Other Operating Expenses | 1.35K Cr | 1.42K Cr | 1.11K Cr | 899.32 Cr | — |
| Depreciation And Amortization In Income Statement | 357.16 Cr | 299.30 Cr | 310.42 Cr | 303.96 Cr | — |
| Amortization | 28.36 Cr | 31.78 Cr | 30.09 Cr | 51.89 Cr | — |
| Depreciation Income Statement | 328.80 Cr | 267.52 Cr | 280.33 Cr | 252.07 Cr | — |
| Selling General And Administration | 1.61K Cr | 1.58K Cr | 1.61K Cr | 1.30K Cr | — |
| Selling And Marketing Expense | 1.29K Cr | 1.28K Cr | 1.32K Cr | 1.05K Cr | — |
| General And Administrative Expense | 316.98 Cr | 302.90 Cr | 299.14 Cr | 247.58 Cr | — |
| Rent And Landing Fees | 10.08 Cr | 9.60 Cr | 9.78 Cr | 6.43 Cr | — |
| Gross Profit | 7.95K Cr | 7.41K Cr | 6.46K Cr | 6.23K Cr | — |
| Cost Of Revenue | 4.86K Cr | 5.03K Cr | 4.98K Cr | 4.28K Cr | — |
| Total Revenue | 12.80K Cr | 12.44K Cr | 11.44K Cr | 10.51K Cr | — |
| Operating Revenue | 12.80K Cr | 12.44K Cr | 11.44K Cr | 10.51K Cr | — |
| Write Off | — | — | 17.04 Cr | 14.96 Cr | -11.49 Cr |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Alkem Laboratories Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.